1. Home
  2. ZLAB vs SHC Comparison

ZLAB vs SHC Comparison

Compare ZLAB & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SHC
  • Stock Information
  • Founded
  • ZLAB 2013
  • SHC 2015
  • Country
  • ZLAB China
  • SHC United States
  • Employees
  • ZLAB N/A
  • SHC N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SHC Medical Specialities
  • Sector
  • ZLAB Health Care
  • SHC Health Care
  • Exchange
  • ZLAB Nasdaq
  • SHC Nasdaq
  • Market Cap
  • ZLAB 4.0B
  • SHC 3.2B
  • IPO Year
  • ZLAB 2017
  • SHC 2020
  • Fundamental
  • Price
  • ZLAB $33.34
  • SHC $16.16
  • Analyst Decision
  • ZLAB Buy
  • SHC Strong Buy
  • Analyst Count
  • ZLAB 6
  • SHC 5
  • Target Price
  • ZLAB $57.22
  • SHC $16.00
  • AVG Volume (30 Days)
  • ZLAB 537.8K
  • SHC 1.7M
  • Earning Date
  • ZLAB 08-07-2025
  • SHC 08-08-2025
  • Dividend Yield
  • ZLAB N/A
  • SHC N/A
  • EPS Growth
  • ZLAB N/A
  • SHC N/A
  • EPS
  • ZLAB N/A
  • SHC 0.08
  • Revenue
  • ZLAB $427,799,000.00
  • SHC $1,124,535,000.00
  • Revenue This Year
  • ZLAB $42.62
  • SHC $6.23
  • Revenue Next Year
  • ZLAB $55.12
  • SHC $5.99
  • P/E Ratio
  • ZLAB N/A
  • SHC $191.15
  • Revenue Growth
  • ZLAB 32.56
  • SHC 2.40
  • 52 Week Low
  • ZLAB $18.91
  • SHC $9.53
  • 52 Week High
  • ZLAB $44.34
  • SHC $17.08
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 43.89
  • SHC 69.91
  • Support Level
  • ZLAB $31.79
  • SHC $15.96
  • Resistance Level
  • ZLAB $35.45
  • SHC $16.55
  • Average True Range (ATR)
  • ZLAB 1.00
  • SHC 0.42
  • MACD
  • ZLAB -0.22
  • SHC -0.03
  • Stochastic Oscillator
  • ZLAB 31.12
  • SHC 77.06

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Share on Social Networks: